7MW3711

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 7MW3711, covering 2023-09-13 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors [Phase 1, Phase 2]